Collateral Sanctions

RSS Feed for this category

Cedars-Sinai Denying Transplant to Medical Marijuana Patient with Inoperable Liver Cancer

PRESS RELEASE

Americans for Safe Access
For Immediate Release:
November 17, 2011
Contact: ASA Chief Counsel Joe Elford or ASA Media Liaison Kris Hermes

Cedars-Sinai Denying Transplant to Medical Marijuana Patient with Inoperable Liver Cancer
Patient advocacy group calls on preeminent health center to change harmful transplant policy

Los Angeles, CA -- Sixty-three year-old medical marijuana patient Norman B. Smith was diagnosed with inoperable liver cancer in 2009 and sought treatment from the internationally lauded Cedars-Sinai Medical Center in Los Angeles. Smith's oncologist at Cedars-Sinai, Dr. Steven Miles, approved of his medical marijuana use as a means to deal with the effects of chemotherapy and pain from an unrelated back surgery. In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list. Smith's cancer was in remission until just recently, but now he is scheduled to undergo radiation treatments in the next few days.

Medical marijuana advocacy group Americans for Safe Access (ASA) issued a letter today urging the Cedars-Sinai Transplant Department to promptly re-list Smith for a liver transplant. The letter also urges Cedars-Sinai to change its transplant eligibility policy. "Denying necessary transplants to medical marijuana patients is the worst kind of discrimination," said ASA Chief Counsel Joe Elford, who also authored the letter to Cedars-Sinai. "Cedars-Sinai would not be breaking any laws, federal or otherwise, by granting Norman Smith a liver transplant, and it's certainly the ethical thing to do."

Smith is not the only medical marijuana patient in the U.S. being denied a transplant. At least one other Cedars-Sinai patient reported to ASA in 2008 that they had been kicked off the transplant list because of their legal medical marijuana use. Over the past four years, ASA has received numerous reports of patients being purged from transplant lists across California, as well as in other medical marijuana states like Hawaii, Oregon, and Washington. In 2008, Seattle resident and medical marijuana patient Timothy Garon died after being denied a liver transplant by the University of Washington Medical Center. A year later, in 2009, Big Island resident and medical marijuana patient Kimberly Reyes died at Hilo Hospital after being denied a liver transplant.

Cedars-Sinai is demanding that Smith not only abstain from marijuana use for at least six months, forcing him to undergo random toxicology tests, but he is also required to participate in weekly substance abuse counseling over the same period. Although Smith was within two months of receiving a transplant before he was de-listed, he will be put at the bottom of the list even after satisfying the policy requirements. "ASA seeks to change this harmful and uncompassionate policy not only for Smith's benefit, but also for the benefit of numerous other medical marijuana patients who are being made to suffer unnecessarily as a result of political ideology," said Elford.

Between January 2010 and October 2011, Smith took part in a rare clinical trial to combat his liver cancer. The trial, which included only 60 people worldwide, involved weekly infusions and daily pills. Smith also smoked medical marijuana during this time, but stopped in August 2011 to try to adhere to the transplant eligibility requirements. Smith was the only patient in the entire 93-week trial who had a successful remission, earning him the moniker of "Miracle Man." Because of the cancer's return, Smith may not have six months to live. However, instead of re-listing him for a transplant, Cedars-Sinai is scheduling him for radiation treatment. "Norman Smith's life hangs in the balance between his desperate need for a liver and an anti-marijuana sentiment that informs a misguided and life-threatening transplant policy," continued Elford.

Smith not only has the support of his oncologist and other Cedars-Sinai staff, but also his psychologist, who wrote a strong letter of recommendation that Smith be approved for a liver transplant. Nonetheless, Dr. Steven D. Colquhoun, the director of Cedars-Sinai's Liver Transplant Program compared Smith's legal medical marijuana use to "substance abuse." In a letter sent to Smith in May, Dr. Colquhoun indicated that the liver transplant center "must consider issues of substance abuse seriously since it does often play a role in the evolution of diseases that may require transplantation, and may adversely impact a new organ after a transplant." Despite Dr. Colquhoun's assertions and Cedars-Sinai's restrictive policy, an independent study has shown that marijuana use has no adverse impact on the survival rate of transplant recipients.

AFI: Norman Smith is available for interviews at 310-801-8370 or normanbsmith55@gmail.com

Further information:
Video of Norman Smith: http://www.youtube.com/watch?v=i_kYTwQ6jdY&feature=youtu.be
ASA letter to Cedars-Sinai: http://AmericansForSafeAccess.org/downloads/Cedars_Letter_ASA.pdf
Cedars-Sinai transplant denial letter to Norman Smith: http://AmericansForSafeAccess.org/downloads/Smith_Transplant_Denial.pdf
Liver transplant study: http://deepblue.lib.umich.edu/bitstream/2027.42/73843/1/j.1600-6143.2008.02468.x.pdf

# # #

 

With over 50,000 active members in all 50 states, Americans for Safe Access (ASA) is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. ASA works to overcome political and legal barriers by creating policies that improve access to medical cannabis for patients and researchers through legislation, education, litigation, grassroots actions, advocacy and services for patients and the caregivers.

Location: 
Los Angeles, CA
United States

Alabama Bill Would Drug Test Medicaid Recipients

Lawmakers in Alabama are pushing the envelope on the drug testing of people who receive public benefits. While legislators in a number of states have targeted welfare or unemployment recipients for drug testing, a bill in Montgomery would require drug testing of Medicaid recipients.

Poor Alabamians who use drugs would be ineligible for Medicaid under a proposed law. (image via Wikimedia)
Distinct from Medicare, the federal program aimed at senior citizens, Medicaid is run by the individual states and is designed to make health care accessible for low-income people who are blind or disabled. It also covers low-income pregnant women, children, seniors, and people residing in nursing homes.

Pre-filed by state Sen. Dick Brewbaker (R-Montgomery), Senate Bill 26, also known as the Patient Accountability and Personal Responsibility Act, would require that Medicaid recipients undergo random suspicionless drug tests at least once each year and that new applicants undergo a drug test before deemed eligible for Medicaid benefits. The cost of the drug tests would be added to recipients' premiums (e.g. poor people will have to pay for the drug tests).

People who fail to take a drug test or test positive would be denied Medicaid benefits. There is no provision for treatment, but those who are thrown off the rolls could be reinstated if they pass another drug test a year later. The drug test results could  not be used in any criminal proceedings "without the consent of the person tested."

The bill would not apply to nursing home residents, prisoners, people in mental hospitals or those in other long-term care facilities.

Lawmakers favoring the bill claimed the number of illegal drug users getting state-funded health care has "skyrocketed" in recent years, with the cost estimated at "unknown millions." State Sen. Arthur Orr (R-Decatur) told WHNT News the proposed law would save taxpayer money while forcing accountability on Medicaid recipients.

"If you want to use drugs and you want the taxpayers to pick up the tab on your health care, if this bill passes, forget about it," said Senator Orr. "If I'm going to use illegal drugs that are going to hurt myself, why ask taxpayers to fund my medical care?"

Random suspicionless drug testing for welfare recipients and state employees have been struck down by various state and federal courts as violating the right to be free of unwarranted searches, although a new Florida welfare drug testing law has yet to be challenged. Lawmakers told WHNT News they thought the Alabama bill is more legally sound because it only deals with public health programs, and if the bill ever becomes law, they are likely to find out in the courts if their legal theory is correct.

SB 26 has passed a first reading and has been assigned to the Senate Health Committee.

Montgomery, AL
United States

No Job Protection for WA Medical Marijuana Patients, Court Rules

Employers in Washington state can fire employees who fail a drug test, even if they have a valid recommendation to use medical marijuana, the state Supreme Court ruled Thursday. The ruling came in the case of a Bremerton woman who was fired from her job after testing positive for pot, although she had a recommendation to use marijuana for migraine headaches.

Taking prescribed Adderall, Oxycontin, or Vicodin? No problem. But medical marijuana can get you fired. (Image via Wikimedia.org
In the case, Jane Roe v. TeleTech Customer Care Management, the anonymous plaintiff was pulled out of a training class and fired in October 2006 because she failed a pre-employment drug test. Her attorney argued that the Washington state medical marijuana law implicitly required employers to accommodate medical marijuana use outside the workplace.

But in an 8-1 decision, the state Supreme Court disagreed. The majority noted that the state law explicitly allows employers to forbid on-the-job medical marijuana use, but says nothing about medical marijuana use outside the workplace.

"We hold that [the Washington Medical Use of Marijuana Act] does not provide a private cause of action for discharge of an employee who uses medical marijuana, either expressly or impliedly, nor does MUMA create a clear public policy that would support a claim for wrongful discharge in violation of such a policy," wrote Justice Charles Wiggins for the majority.

But in his dissent, Justice Tom Roberts noted that under the medical marijuana law, qualified patients "shall not be penalized in any manner, or denied any right or privilege, for such actions." Roberts added that, "Roe seems to be exactly the sort of person the people intended to protect... Neither I nor the law would require employers to employ drug impaired workers. The law is intended to treat marijuana like any other medication."

If the state high court will not protect the rights of Roe, Roberts wrote, the legislature should step up and do so. "To that end, I urge the legislature to thoughtfully review and improve the act."

But that's no easy process. In California, which has seen a similar state court ruling gutting the employment rights of medical marijuana users, a legislative effort to provide a fix died in Sacramento last week.

Olympia, WA
United States

Drug Courts Poor Public Policy, Reports Charge [FEATURE]

With a pair of separate reports released Tuesday, the Drug Policy Alliance (DPA) and the Justice Policy Institute (JPI) have issued a damning indictment of drug courts as a policy response to drug use. Instead of relying on criminal justice approaches like drug courts, policymakers would be better served by moving toward evidence-based public health approaches, including harm reduction and drug treatment, as well as by decriminalizing drug use, the reports conclude.

Since then-Dade County District Attorney Janet Reno created the first drug court in Miami in 1989, drug courts have appeared all over the country and now number around 2,000. In drug courts, drug offenders are given the option of avoiding prison by instead pleading guilty and being put under the scrutiny of the drug court judge. Drug courts enforce abstinence by imposing sanctions on offenders who relapse, including jail or prison time and being thrown out of the program and imprisoned on the original charge. The Obama administration wants to provide $57 million in federal funding for them in its FY 2012 budget.

Through organizations like the National Association of Drug Court Professionals  (NADCP), the drug court movement has created a well-oiled public relations machine to justify its existence and expansion. NADCP maintains that the science shows that drug courts work and even maintains a convenient response to criticisms leveled by earlier critics.

The Chronicle contacted NADCP for comment this week, but representatives of the group said they were still digesting the reports and would issue a statement in a few days.

But in a Monday teleconference, DPA, JPI, and the National Association of Criminal Defense Lawyers (NACDL), which issued its own critical report on America's Problem-Solving Courts in 2009, slashed away at drug court claims of efficacy and scientific support. Drug courts are harsh on true addicts, don't benefit the public health or safety, and are an inefficient use of criminal justice system resources, they said.

"The drug court phenomenon is, in large part, a case of good intentions being mistaken for a good idea," said Margaret Dooley-Sammuli, DPA's Southern California state deputy director and co-author of the DPA report, Drug Courts are Not the Answer: Toward a Health-Centered Approach to Drug Use. "Drug courts have helped many people, but they have also failed many others, focused resources on people who could be better treated outside the criminal justice system and in some cases even led to increased incarceration. As long as they focus on people whose only crime is their health condition, drug courts will be part of the problem -- not the solution -- created by drug war policies," she said.

"Even if drug courts were able to take in all 1.4 million people arrested for just drug possession each year, over 500,000 to 1 million people would be kicked out and sentenced conventionally," Dooley-Sammuli added. "Drug courts just don't make sense as a response to low-level drug violations."

The DPA report found that drug courts have not demonstrated cost savings, reduced incarceration, or improved public safety. Previous "unscientific and poorly designed research" supporting drug courts has failed to acknowledge that drug courts often "cherry pick" people expected to do well, that many petty drug law violators choose drug courts because they are offered a choice of treatment or jail and drug courts thus are not diverting large numbers of people from long prison sentences, or that, given their focus on low-level drug violators, even positive results for individuals accrue few public safety benefits for the community.

Not only are drug courts' successes unproven, DPA said, they are often worse for the people participating in them. Their quick resort to incarceration for relapses means some defendants end up serving more time than if they had stayed out of drug court. And defendants who "fail" in drug court may face longer sentences because they lost the opportunity to plead to a lesser charge. In addition, the existence of drug courts is associated with increased arrests and imprisonment because law enforcement and others believe people will "get help" if arrested.

Worst, the DPA report found, drug courts are toughest on those who most need treatment for their addictions. Because of their use of quick sanctions against those who relapse, the seriously addicted are more likely to end up incarcerated for failing to stay clean, while those who don't have a drug problem are most likely to succeed. Drug courts typically don't allow what Dooley-Sammuli called the "gold standard" of treatment for opiate addiction, methadone or other maintenance therapies.

Drug courts should be reserved for cases involving offenses against persons and property committed by people who have substance abuse problems, while providing other options such as probation or treatment for people arrested for low-level drug law violations, the report recommended. It also called for bolstering public health systems, including harm reduction and drug treatment programs, to deal with drug use outside the criminal justice system, and for decriminalizing drug use to end the problem of mass arrests and incarceration.

"Drug courts are not a true alternative to incarceration," said Natassia Walsh, author of the JPI report, Addicted to Courts: How a Growing Dependency on Drug Courts Impacts People and Communities. "They are widening the net of criminal justice control. Even the mere existence of a drug court means more people are arrested for drug offenses, which brings more people into the criminal justice system, which means increased costs for states and localities, as well as for offenders and their families."

The JPI report found that providing people with alternatives like community-based drug treatment are more cost-effective and have more public safety benefits than treatment attached to the criminal justice system, with all its collateral consequences.

"It is shameful that for many people, involvement in the criminal justice system is the only way to access substance abuse treatment in this country," said Walsh. "We need to change the way we think about drug use and the drug policies that bring so many people into the justice system. The dramatic increase in drug courts over the past 20 years may provide talking points for so-called 'tough-on-crime' policymakers; however, there are other, better options that can save money and support people and communities. More effective, community-based programs and services that can have a positive, lasting impact on individuals, families and communities should be available."

"All three of our reports have some things in common, " said the NACDL's Elizabeth Kelly. "They recognize that substance abuse is a public health issue not appropriate for the criminal justice system to handle, they recognize that these problem-solving courts cherry pick their participants, allowing them to inflate success rates, and they recognize that drug courts exclude the people who are most problematic and who have the most profound addictions," she said.

"It is fundamentally bad public policy to make the only means to treatment through the criminal justice system that stigmatizes and burdens the individual with all the collateral consequences of a criminal conviction," Kelly concluded.

The fight to avoid the drug policy dead end that is drug courts is on.

Mass Marijuana Arrest Policy Costs NYC Big Bucks

In a report released Tuesday, the Drug Policy Alliance charged that New York City's unwritten policy of mass arrests of pot smokers -- overwhelmingly young and minority -- is costing the city $75 million a year. The report, bluntly titled $75 Million a Year: The Cost of New York City's Marijuana Arrests, was co-authored by City University of New York professor and marijuana arrest expert Harry Levine.

drug arrest scene, "10 Rules for Dealing with Police," flexyourrights.org
Although New York state decriminalized marijuana possession in the 1970s, the NYPD has made it a practice to stop and frisk people by the hundreds of thousands a year and demand that they empty their pockets. When they produce marijuana from their pockets, they are then charged with public possession -- possession in plain view -- a misdemeanor.

The NYPD is arresting about a thousand pot smokers a week and has busted more than 350,000 of them during Mayor Michael Bloomberg's tenure in office. This is the same Mayor Bloomberg who once said he smoked marijuana and like it.

Bloomberg's and the NYPD's mass arrest policies cost the city big bucks in a time of economic difficulty. With Levine and his co-author Loren Siegel estimating the cost of arresting and prosecuting each pot possession offender at between $1,000 and $2,000, New York City has spent somewhere between $350 million and $700 million to persecute pot people since Bloomberg has been in office.

"More people have been arrested for marijuana possession under Mayor Bloomberg than under Mayors Koch, Dinkins, and Guiliani combined," said Levine at a City Hall news conference Tuesday. "These arrests are wildly expensive, do not improve public safety, and create permanent criminal records which seriously damage the life chances of the young people targeted and jailed," Levine said.

"Upwards of $75 million have been used to arrest NYC residents for marijuana possession that could have legally been handled with a summons and not a criminal offense," said City Council Member Jumaane Willimas. "This, as we are debating closing our senior centers. In addition, 86% of those arrests are young children of more color. I don't believe that this represents the percentage of people who take the occasional 'pull.'  It does however better reflect the communities abused by the current stop and frisk policies. Had this been 86% of our young children of a lighter shade, there would be uproar. I believe there still should be. All of our children are gifts to be nurtured; yet we are losing them to the system at an alarming rate. There must be a better way to deal with drugs in New York City. These arrests are simply about boosting arrest numbers and aren't the answer to our problems," said Williams.

"It is clear that the NYPD's current policy of giving high arrest priority to marijuana enforcement is fiscally wasteful, and has a greater impact on low-income communities where the 'war-on-drugs' has been primarily focused," said Council Member Letitia James. "Although African-Americans only constitute 13% of national of drug users, they make up 38% of those arrested for drug offenses, and 59% of those convicted of drug offenses. It is fair to say that the high priority given to marijuana enforcement directly relates to racial profiling in New York."

"The consequences of an arrest are severe, especially for young people of color who are already disproportionately arrested and incarcerated in juvenile facilities," said Kyung Ji Rhee, Director of the Institute for Juvenile Justice Reform and Alternatives. "Young people of color are targeted, illegally searched and being put through the criminal justice system for possessing or smoking marijuana. Whatever your opinion may be on marijuana, this is no way to treat or teach young people about the choices they make."

"It is beyond hypocritical for the Mayor, who once said he smoked marijuana and enjoyed it, to make arresting young people of color for marijuana possession his top law enforcement priority," said Gabriel Sayegh, New York State Director for the Drug Policy Alliance. "While cutting services for seniors, youth, housing, transportation, teachers, education, and more, the Mayor spent S75 million last year to arrest over 50,000 people for marijuana possession -- which isn’t even a crime under NY State law. It's just outrageous."

Will Mayor Bloomberg and the NYPD see the light? Not without some political heat -- stay tuned.

New York, NY
United States

Life After the War on Drugs: Reviewing Past and Present Policies with an Eye Toward Legal Reform

University of the District of Columbia David A. Clarke School of Law
2011 Law Review Symposium

David A. Clarke School of Law
 

"Life After the War on Drugs: Reviewing Past and Present Policies With an Eye Toward Legal Reform"


Introduction (10:00 – 10:15 a.m.)
• John Brittain, Professor, UDC-DCSL, Chief Counsel and Senior Deputy Director of the Lawyers' Committee for Civil Rights Under Law (2005-2009)

Panel 1: Drug Policy at Home and Abroad (10:15 a.m. – 12:00 p.m.)
• Eric Sterling, Advisory Board Member, Law Enforcement Against Prohibition (LEAP)
• Brooke Mascagni, PhD Candidate, University of California, Santa Barbara
• Jordan Blair Woods, PhD Candidate, Cambridge University (U.K.), J.D. University of California Los Angeles

Lunch (12:00 – 1:00 pm)
• Lunch Keynote Speaker: Ronald C. Machen, Jr., United States Attorney for the District of Columbia

Panel 2: Conflicts between State and Federal Drug Laws (1:00 – 3:30 p.m.)
• Andrew Ferguson (Moderator), Professor, UDC-DCSL, Public Defender Service of the District of Columbia (2004-2010)
• Robert Hildum, Director, D.C. Dept. of Youth Rehabilitation Services (2010)
• Sumeet H. Chugani, Esq. and Xingjian Zhao, Esq., Diaz, Reus & Targ, LLP (Miami, FL)
• Alex Kreit, Director, Center for Law and Social Justice, Thomas Jefferson School of Law (San Diego, CA)

Panel 3: The Unknown Effects of the War on Drugs (3:45 – 5:00 p.m.)
• Brian Gilmore, Director, Michigan State University College of Law Housing Clinic
• Ken Lammers, Deputy Commonwealth Attorney, County of Wise and City of Norton in Virginia
• Michael Liszewski, Board of Directors, Students for Sensible Drug Policy

Cocktail Reception (5:10 – 6:00 p.m.)

Plenary Panel: Life After the War on Drugs (6:00 – 9:00 p.m.)
• Keynote Speaker: Wade Henderson, President and CEO, The Leadership Conference on Civil and Human Rights
• Jasmine Tyler, Deputy Director of National Affairs, Drug Policy Alliance
• Mark Osler, Professor, University of St. Thomas School of Law (Minneapolis, MN)
• The Honorable Arthur L. Burnett, Sr., National Executive Director, National African-American Drug Policy Coalition
• Dr. Faye Taxman, Director, Center for Advancing Correctional Excellence, George Mason University

The event is free and open to the public, but registration is limited. To register, see http://www.law.udc.edu/events/event_details.asp?id=136549.

For any questions, please contact Symposium Editor Leila Mansouri at Leila.Mansouri@udc.edu.

Date: 
Thu, 03/24/2011 - 10:00am - 9:00pm
Location: 
4200 Connecticut Avenue, NW University of the District of Columbia David A. Clarke School of Law, Windows Lounge: Building 38, 2nd Floor
Washington, DC 20008
United States

Washington State Medical Marijuana User Dies Without Transplant

Location: 
WA
United States
Timothy Garon, a musician who was denied a liver transplant because he used marijuana with medical approval under Washington state law to ease the symptoms of advanced hepatitis C, died. Dr. Brad Roter, the physician who authorized Garon to use medical marijuana to alleviate for nausea and abdominal pain and to stimulate his appetite, said he did not know it would be such a hurdle if Garon were to need a transplant.
Publication/Source: 
KBOI (ID)
URL: 
http://www.kboi2.com/news/local/117191348.html

Cannabis Council Reaches Out to Help Colorado Teenager Denied Access to Medical Marijuana for Very Rare Condition

Location: 
Colorado Springs, CO
United States
Mark Slaugh, membership director of the Colorado Springs Medical Cannabis Council, wrote to Rep. Mark Barker, R-Colorado Springs, and Sen. John Morse, D-Colorado Springs to urge legislative action on behalf of a teenage medical marijuana patient being denied access to his medicine by Colorado's Harrison School District 2. The teenager in question was diagnosed a little more than a year ago with a very rare condition that causes seizures, which can last for days. Slaugh said the district should take a more reasonable approach to the situation and the legislature should rewrite medical marijuana laws so that this situation doesn’t come up in the first place.
Publication/Source: 
The Colorado Independent (DC)
URL: 
http://coloradoindependent.com/74315/cannabis-council-reaches-out-to-help-teenager

Law Student Sues St. John’s University for Rescinding Readmission Over Drug Charges

Location: 
8000 Utopia Parkway St. John’s University
Queens, NY 11439
United States
David Powers, an accountant who took time out of law school at St. John’s University, has sued the Roman Catholic university in New York after it refused to readmit him, saying that he had not been honest about a criminal conviction, since expunged, in his past. Three semesters into his law degree, Mr. Powers was granted a leave of absence to manage a $2-billion investment fund in Hong Kong.
Publication/Source: 
The Chronicle of Higher Education (DC)
URL: 
http://chronicle.com/blogs/ticker/law-student-sues-st-johns-u-for-rescinding-readmission-over-drug-charges/30251

California Chamber of Commerce in Anti-Prop 19 Radio Attack Ad Campaign

The California Chamber of Commerce has begun a $250,000 radio ad campaign against Proposition 19, the tax and regulate marijuana legalization initiative. The first ads hit the airwaves last Friday, the business group announced in a statement.

Here is the Prop 19 language that has the Chamber so bestirred: "No person shall be punished, fined, discriminated against, or be denied any right or privilege for lawfully engaging in any conduct permitted by this Act or authorized pursuant to Section 11301 of this Act. Provided however, that the existing right of an employer to address consumption that actually impairs job performance by an employee shall not be affected."

The Chamber wants employers to continue to be able to fire workers for failing a drug test for marijuana, even though such test do not measure actual impairment, but only the presence of metabolites in the body. Those metabolites can remain for days or even weeks after the psychoactive effects of marijuana have worn off.

"Imagine coming out of surgery and the nurse caring for you was high or having to work harder on your job because a co-worker shows up high on pot," intones a woman's voice in the ad. "It could happen in California if Proposition 19 passes. Prop 19 would do more than simply legalize marijuana.  Prop 19 is worded so broadly is would hurt California's economy, raise business costs and make it harder to create jobs."

The Chamber has prepared a legal analysis that argues that Prop 19 would create a "protected class" of pot-smoking workers, and "expose workers to increased risk of injury, jeopardize federally funded projects and jobs, and add more liabilities and costs to already overburdened employers." 

"The employer impacts and workplace safety concerns highlighted in CalChamber’s legal analysis have been prominently featured in the many statewide editorials opposing Proposition 19," said Allan Zaremberg, president and CEO of the California Chamber of Commerce. "We want to be sure we reinforce the facts with voters so they understand that this measure will undermine the ability of employers to ensure a safe work environment and create higher costs for those who provide and create jobs."

In addition to the Reefer Madness-style fear-mongering already cited, the Chamber ad falsely claims that "employees would be able to come to work high, and employers wouldn’t be able to punish an employee for being high until after a workplace accident," when the initiative clearly states they can sanction actual impairment.

It's the final stretch in the campaign, and big business has begun the mud-slinging.

CA
United States

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum), Synthetic Drugs (Mephedrone, Synthetic Cannabinoids)YouthGrade School, Post-Secondary School, Raves, Secondary School